Industry Symposia
18 September 2025 (Thursday), 7:55–8:55
Cubex A1 + A2
Vertex
B Cells: Key Culprits in the Pathogenesis of IgA Nephropathy
- Jürgen Floege, RWTH Aachen University, Aachen, Germany (Chair/Moderator)
- Chee Kay Cheung, University of Leicester, Leicester, UK
- Heather Reich, UHN-Toronto General Hospital, Toronto, Canada
An invitation is available here.
18 September 2025 (Thursday), 13:00–14:00
Cubex A1 + A2
STADA + Calliditas
Changing the Natural History of IgA Nephropathy: What Does Disease Modification Mean?
Welcome and introduction
Jonathan Barratt (chair)
Addressing the drivers of disease in IgAN: Where are we now?
Dana Rizk
Disease modification concepts in IgAN: An interactive panel discussion
Jonathan Barratt, Dana Rizk, Valdimir Tesar
Summary and close
Jonathan Barratt
18 September 2025 (Thursday), 16:00–17:00
Cubex A1 + A2
Otsuka
Rethinking What We Know About IgA Nephropathy: From Pathogenesis to Practice
Welcome and introductions
Vladimír Tesař
Video presenting the patient voice in IgAN
IgAN disease burden and risk of progression
Dana Rizk
Review of IgAN pathogenesis
Bobby Chacko
Evolving IgAN management in light of new pathogenic understanding
Bobby Chacko
Case studies
All Faculty
Q&A
All Faculty
An invitation is available here.
19 September 2025 (Friday), 07:55–08:55
Cubex A1 + A2
Vera Therapeutics
Controversies in IgA Nephropathy: A Panel Discussion
- Jonathan Barratt, UK (Chair and Moderator)
- Richard Lafayette, USA
- Hernán Trimarchi, Argentina
- Suceena Alexander, India
- Dana Rizk, USA
An invitation is available here.
19 September 2025 (Friday), 13:00–14:00
Cubex A1 + A2
CSL Vifor
Precision Medicine in IgAN: A Deep Dive Into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
- Chee Kay Cheung, University of Leicester, Leicester, UK
- Raphaël Duivenvoorden, Radboud University Medical Center, Nijmegen, the Netherlands
An invitation and registration is available here.
20 September 2025 (Saturday), 08:05–08:50
Cubex A1 + A2
Novartis
Immunoglobulin A nephropathy (IgAN) in focus: redefining diagnosis, reimagining management
Welcome and introduction
Hernán Trimarchi (Chair)
Adjusting the lens: collaborative innovation in IgAN care
Hernán Trimarchi, Heather Reich, and Ian Roberts
Summary and close
Hernán Trimarchi (Chair)
An invitation is available here.
This symposium is organized and funded by Novartis and is intended for an audience of non-US/-UK healthcare professionals within the context of the IIgANN 2025 Congress in Prague, Czech Republic.
20 September 2025 (Saturday), 13:00–14:00
Cubex A1 + A2
Roche
New insights and approach to target the complement system in IgAN
Welcome and introduction
Vladimir Tesař, Prague, Czech Republic (chair)
Targeting the complement system in IgAN
Irene Noronha, São Paulo, Brazil
Complement biomarkers and beyond
Hong Zhang, Beijing, China
New generation of complement therapeutics on the horizon
Jonathan Barratt, Leicester, UK
Q&A and closing remarks
Vladimir Tesař, Prague, Czech Republic
An invitation is available here.
This symposium is not intended for physicians practising in the USA.
Last update on 21 August 2025.
The programme might be subject to necessary changes.
